Documents
Application Sponsors
ANDA 211089 | ALKEM LABS LTD | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
None (Tentative Approval) | 004 |
Application Products
001 | TABLET;ORAL | 5MG | 0 | VORTIOXETINE | VORTIOXETINE |
002 | TABLET;ORAL | 10MG | 0 | VORTIOXETINE | VORTIOXETINE |
003 | TABLET;ORAL | 15MG | 0 | VORTIOXETINE | VORTIOXETINE |
004 | TABLET;ORAL | 20MG | 0 | VORTIOXETINE | VORTIOXETINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2019-08-21 | STANDARD |
Submissions Property Types
CDER Filings
ALKEM LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211089
[companyName] => ALKEM LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"VORTIOXETINE","activeIngredients":"VORTIOXETINE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VORTIOXETINE","activeIngredients":"VORTIOXETINE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VORTIOXETINE","activeIngredients":"VORTIOXETINE","strength":"15MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VORTIOXETINE","activeIngredients":"VORTIOXETINE","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/21\/2019","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/211089Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-08-21
)
)